45 studies found for:    Open Studies | "Staphylococcal Infections"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73
Condition: Staphylococcal Infection
Interventions: Other: Placebo;   Drug: XF-73 in 4% Klucel gel;   Drug: XF-73 in 2% Klucel gel
2 Recruiting Safety and Efficacy of Intranasal and Topical Mupirocin in Eradicating Colonization With Staphylococcus Aureus (SA) in Critically Ill Infants - a Phase 2, Multi-Center, Open Label, Randomized Trial
Condition: Staphylococcal Infection
Intervention: Drug: Mupirocin calcium
3 Unknown  Preoperative Nasal Swabs From Pediatric Patients
Condition: Staphylococcal Infections
Intervention: Procedure: Nose swab
4 Not yet recruiting Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection
Condition: Staphylococcal Infections
Intervention: Drug: Daptomycin
5 Unknown  A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely
Condition: Staphylococcal Infections
Intervention: Drug: teicoplanin
6 Unknown  Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant
Condition: Staphylococcal Infections
Intervention:
7 Recruiting Randomized, Multicenter, Double-blind, Vancomycin-controlled Study to Evaluate the Efficacy of Ethanol Lock Solution for the Curative Treatment of Implantable Venous Access Port Infection Due to Coagulase-negative Staphylococci
Conditions: Lock Solution;   Catheter Related Blood Stream Infections;   Central Venous Catheter Infection;   Intravenous Drug Delivery Systems;   Coagulase-negative Staphylococci Infection
Interventions: Drug: Ethanol 40% + Enoxaparine 400UI/ml;   Drug: Vancomycine 5 mg/ml + Héparine 2500UI/ml
8 Recruiting Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial
Conditions: Staph Aureus Colonization;   Staph Aureus Infection
Interventions: Drug: Mupirocin and Chlorhexidine;   Drug: Placebo ointment and placebo cloths
9 Recruiting Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
Condition: Staph Aureus Methicillin Resistant Bacteremia
Interventions: Drug: Fosfomycin 2gr/6h iv;   Drug: Daptomycin  10mg/kg/24h iv
10 Recruiting Impact of Mupirocin Decolonization on the Nasal Microbiome
Condition: Nasal Colonization With Staph Aureus
Intervention:
11 Unknown  Vascular Surgical Antibiotic Prophylaxis Study (VSAPS 2)
Condition: MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Intervention: Drug: Antibiotic Prophylaxis
12 Unknown  Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia
Conditions: Methicillin-resistant Staphylococcus Aureus;   Pneumonia, Ventilator-Associated
Intervention: Drug: Imipenem/cilastatin
13 Recruiting Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Conditions: Bacterial Infection;   Benign Neoplasm;   Malignant Neoplasm;   Methicillin-Resistant Staphylococcus Aureus Infection;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Untreated Childhood Myeloid Neoplasm
Interventions: Drug: Chlorhexidine Gluconate;   Procedure: Wound Care Management;   Other: Questionnaire Administration;   Other: Laboratory Biomarker Analysis
14 Recruiting Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
Condition: Cystic Fibrosis
Interventions: Drug: Inhaled Vancomycin;   Drug: Placebo (Sterile Water);   Drug: Rifampin;   Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX);   Drug: Doxycycline;   Drug: Mupirocin Nasal Ointment;   Drug: 4% chlorhexidine gluconate liquid skin cleanser
15 Recruiting Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients
Condition: MRSA - Methicillin Resistant Staphylococcus Aureus Infection
Interventions: Drug: Vancomycin continuous infusion;   Drug: Vancomycin intermittent dosing interval
16 Unknown  A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)
Condition: Infection
Interventions: Dietary Supplement: Lactobacillus rhamnosus;   Dietary Supplement: Sugar pill (placebo)
17 Recruiting Biotherapy for MRSA Enterocolitis
Condition: Methicillin-Resistant Staphylococcus Aureus
Intervention: Other: Fecal microbiota transplantation
18 Recruiting Safety and Efficacy of BAY1192631 in Japanese Patients With Methicillin-resistant Staphylococcus Aureus (MRSA) Infections
Condition: Skin Diseases, Infectious
Interventions: Drug: Tedizolid(BAY1192631);   Drug: Linezolid
19 Unknown  Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Skin and Soft Tissue Abscess Undergoing Incision and Drainage
Conditions: Skin and Soft Tissue Abscess;   Methicillin-resistant Staphylococcus Aureus (MRSA) Infection
Intervention: Drug: Oral Clindamycin
20 Not yet recruiting Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection
Condition: Methicillin-Resistant Staphylococcus Aureus
Intervention: Drug: Beta-Lactam

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years